The biotech perception has changed mate, most beaten down IPOs from past 18 months have significantly recovered on ASX and TRP is no exception. TRP is in good shape to deliver significant milestones in next 12 months and adequately funded to get phase 3 completion without dilution, thus still have more room to catch up in the ASX biotech space, when perception changes holders refuse to sell and in happy to wait mode thus up move requires only thin buying mate, I see nothing wrong and the up moves in last couple of weeks I noticed to comparable ASX candidates below and TRP is still behind :-(
CU6 40%
CHM 35%
RAD 35%
Ann: Lodgement of Type C Meeting Request with US FDA, page-12
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.39M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 43.0¢ | 39.0¢ | $102.0K | 248.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 352 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 1500 | 1 |
View Market Depth
| Last trade - 15.44pm 30/08/2024 (20 minute delay) ? |
| TRP (ASX) Chart |